In conclusion, in this study, we characterized the genetic profile of CD5+ DLBCL by PIM1, MYD88, and CD79B mutations, with MCD and ABC subtypes commonly observed. This evidence concerns the gene MYD88 and diffuse large B-cell lymphoma.